Florfenicol is a veterinary antibiotic belonging to the phenicol family, related to chloramphenicol and thiamphenicol but developed exclusively for animal use. It was designed to deliver broad-spectrum antibacterial protection while avoiding the toxic effects that limited its older relatives. Chemically, it’s a fluorinated analogue of thiamphenicol — a small change that makes it more stable and harder for bacteria to resist. Florfenicol works by binding to the 50S subunit of bacterial ribosomes and blocking the enzyme that builds essential proteins. Once that process is disrupted, bacteria can no longer grow or reproduce, slowing or halting the infection. It’s primarily bacteriostatic, but at higher concentrations can become bactericidal. The drug’s design also helps it bypass acetylation, a common bacterial resistance mechanism that often renders older antibiotics ineffective [1][2].
How It’s Used in Animals
Florfenicol has a wide range of applications in veterinary medicine and aquaculture. In cattle it is a frontline treatment for bovine respiratory disease caused by Mannheimia haemolytica, Pasteurella multocida and Histophilus somni [1]. In pigs it’s used to manage respiratory and systemic infections involving Actinobacillus pleuropneumoniae and Glaesserella parasuis [1]. It has also become one of the few antibiotics authorised internationally for use in aquaculture, particularly in salmon and trout farming, where dense populations make bacterial outbreaks difficult to control [3]. Its ability to distribute quickly throughout tissues and maintain therapeutic levels in blood and organs makes it valuable for treating systemic infections. However, as with all antibiotics used in food-producing animals, its use is tightly regulated to prevent residues entering the food chain and to minimise resistance [4].
Land management, farming and habitat pressures all intersect with how veterinary chemicals move through the landscape. This page outlines why healthy forests and intact habitats remain critical for wildlife.
Explore → /forest-and-habitat-conservation
Pharmacology and Animal Health Considerations
When given by injection or through feed, florfenicol is efficiently absorbed and distributed throughout an animal’s body, including the lungs, kidneys and liver [5]. It’s metabolised in the liver and eliminated through the urine, which means residues can persist for a time after treatment. Withholding periods are therefore crucial: meat, milk or fish must not enter the food chain until the specified interval has passed. These waiting times vary depending on the species, the environment and the route of administration. The antibiotic is unsuitable for all animals — in horses, for instance, it can cause severe colitis and is generally avoided [3]. For wildlife, where pharmacological data are limited, any use should be guided by a vet experienced with native species. Inappropriate dosage or duration can do more harm than good, both to the animal and the broader microbial environment.
Environmental and Resistance Concerns
Although florfenicol is more resilient to resistance than older drugs, overuse or misapplication can still encourage the development of resistant bacterial strains [1][6]. Studies have identified resistance genes in aquatic environments linked to the presence of florfenicol residues, showing that misuse in one system can affect another. The antibiotic’s metabolites have been found in sediments near aquaculture facilities, raising concerns about impacts on microscopic organisms that support nutrient cycling and ecosystem health [7]. Environmental persistence also increases the chance of exposure to non-target species. For this reason, antibiotic stewardship — the careful, minimal, evidence-based use of antimicrobial agents — has become a global priority. In aquaculture, best practice focuses on prevention: vaccination, improved water quality, lower stocking densities and strong biosecurity [8]. In terrestrial farming, herd health management and targeted diagnosis are the preferred alternatives to blanket antibiotic use [9].
The Tasmanian Context
Florfenicol entered public discussion in Tasmania in late 2025, when the state’s salmon farming industry faced a severe outbreak of Piscirickettsia salmonis, a bacterial pathogen responsible for high mortalities in farmed Atlantic salmon [10]. To control the outbreak, the Australian Pesticides and Veterinary Medicines Authority (APVMA) granted an emergency permit allowing florfenicol to be used in medicated feed for Tasmanian salmon [11]. The approval, issued for a limited period, marked the first time this antibiotic had been authorised for aquaculture use in Australia [12]. The Environment Protection Authority Tasmania (EPA Tasmania) and the Department of Natural Resources and Environment Tasmania oversee compliance. Under the conditions of the permit, fish treated with florfenicol must remain unharvested for at least 300 degree-days — roughly three weeks — after treatment to ensure that residues have cleared [3]. The EPA is responsible for monitoring water and sediment quality around fish pens, while the Tasmania Department of Health provides public advice when treatments occur [10].
Responsible antibiotic use is closely tied to the health of our broader environment. This piece explores how small individual choices help safeguard the wild places our native species depend on.
Explore → /protecting-our-wild-places
The Department of Health recommended that recreational fishers avoid eating wild fish caught within three kilometres of salmon pens during treatment and for around 21 days afterwards [12]. Officials emphasised that this was a precaution rather than an indication of known risk; current evidence suggests no harm from trace residues [12]. Even so, the advisory underscored public concern about antibiotic use in open-water systems. For conservationists, wildlife carers and environmental scientists, Tasmania’s emergency approval has become a case study in balancing animal health with ecosystem integrity. While florfenicol is regarded as one of the safer antibiotics available, its introduction into a marine environment brings unavoidable questions about how residues move through food webs and how antibiotic-resistant genes might circulate in wild microbial communities [13].
Debate and Oversight
The decision to permit florfenicol use in Tasmanian aquaculture has drawn mixed reactions. Industry groups argue that the treatment was essential to prevent mass mortality and that similar antibiotics are used responsibly in Norway and Chile, two of the world’s major salmon-farming nations [13]. They also point out that florfenicol has a relatively short withholding period and low toxicity, making it a pragmatic choice in emergencies. Environmental organisations, however, have called for greater transparency, independent residue testing and the publication of environmental monitoring data [14]. Some have expressed concern that the approval process was fast-tracked without full environmental impact assessment [15]. Trade and export bodies are also paying close attention, since the presence of antibiotic residues — even below regulatory limits — can affect market access in countries with strict import requirements [11].
For wildlife and conservation professionals, the implications extend beyond the salmon industry. Wild fish, seabirds and marine mammals can come into contact with antibiotic residues or consume medicated feed pellets that escape pens [7]. The long-term ecological consequences remain uncertain, but the situation highlights the importance of comprehensive environmental monitoring and responsible oversight [7].
Allegations of Off-Label Use
Further scrutiny of florfenicol’s introduction in Tasmania arose following a Tasmanian Times investigation that examined Right to Information (RTI) documents obtained in October 2025. According to the publication, internal government correspondence suggested that salmon-industry representatives were advised months before the formal emergency permit that florfenicol could be used “off-label” under veterinary prescription. The advice, reportedly issued by an agricultural chemicals program manager in February 2025, indicated a potential pathway to use the antibiotic without full regulatory approval from the APVMA [7].
A Shared Responsibility
Florfenicol’s story in Tasmania reflects the delicate balance between animal welfare, food production and environmental protection. Antibiotics remain indispensable in modern medicine, yet every dose carries ecological consequences. Responsible use means applying them only when necessary, following strict dosage and withholding guidelines, and supporting research into safer, non-antibiotic alternatives. The emergency approval for florfenicol in Tasmania serves as both a cautionary example and a reminder of the complex intersections between science, regulation and public confidence [15].
Biosecurity challenges, from emerging diseases to chemical exposures, shape the resilience of wildlife populations. This resource explains how these pressures interact across Tasmania. Explore → /disease-and-biosecurity-threats
In the years ahead, success will depend on collaboration between aquaculture operators, government agencies, researchers and conservation groups to ensure that disease management in farmed animals does not come at the expense of the ecosystems that sustain them. For those working in wildlife rescue or environmental protection, this is an opportunity to stay engaged and to advocate for transparent reporting, strong stewardship policies, and the careful integration of veterinary science with environmental ethics [13].
References
- Mercer MA, “Phenicols Use in Animals – Pharmacology”, MSD Veterinary Manual, reviewed Sept 2022.
- ScienceDirect Topics, “Florfenicol – an overview”.
- EPA Tasmania, “Florfenicol – Management of Therapeutants (including antibiotics)”.
- APVMA, “Minor Use and Emergency Permits”.
- NBINNO, “The Pharmacological Profile of Florfenicol: A Deep Dive for Veterinary Use”.
- NBINNO, “The Science Behind Florfenicol: Mechanism of Action and Resistance”.
- Tasmanian Times, “Smoking Gun – RTI Documents Expose Salmon Cover-Up”.
- NBINNO, “The Mechanism of Action: How Florfenicol Fights Bacterial Infections”.
- NBINNO, “The Science Behind Florfenicol: Mechanism, Application and Future”.
- Department of Natural Resources and Environment Tasmania, “Approval of Antibiotic for Use in Salmon”.
- APVMA Trade Advice Notice, “Florfenicol for Emergency Use on Atlantic Salmon”.
- ABC News, “Tasmanian farmed salmon industry granted emergency federal approval to use florfenicol antibiotic”.
- Pulse Tasmania, “Florfenicol: Tasmanian Salmon Industry Gets Antibiotic Approval – Already Using It”.
- Tasmanian Greens, “Big Salmon Putting Profits Before People and the Environment”.
- Tasmanian Greens, “Salmon Industry Florfenicol Fast-Tracking”.
Leave a Reply